July 7, 2026 · Form 4 insider transaction
Almstead Neil Gregory bought 24,613 shares of PTC Therapeutics, Inc. at $39.42 per share, a transaction worth $970.2K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on November 11, 2025.